Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group.

Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC.

Neurology. 1994 Mar;44(3 Pt 1):442-6.

PMID:
8145913
2.
4.

The influence of handedness on the distribution of muscular weakness of the arm in facioscapulohumeral muscular dystrophy.

Brouwer OF, Padberg GW, van der Ploeg RJ, Ruys CJ, Brand R.

Brain. 1992 Oct;115 ( Pt 5):1587-98.

PMID:
1422805
5.

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC.

Neurology. 1997 Jan;48(1):46-9.

PMID:
9008492
6.

Quantitative motor assessment in myotonic dystrophy.

Mathieu J, Boivin H, Richards CL.

Can J Neurol Sci. 2003 May;30(2):129-36.

PMID:
12774952
7.

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.

Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D.

Ann Neurol. 1996 Jun;39(6):744-8.

PMID:
8651646
8.

Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R.

Neurology. 1998 May;50(5):1402-6.

PMID:
9595995
9.

Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial.

Payan CA, Hogrel JY, Hammouda EH, Lacomblez L, Ollivier G, Doppler V, Eymard B, Attarian S, Pouget J, Desnuelle C, Laforêt P.

Arch Phys Med Rehabil. 2009 Jul;90(7):1094-101. doi: 10.1016/j.apmr.2008.12.027.

PMID:
19577021
10.

Beevor's sign and facioscapulohumeral dystrophy.

Awerbuch GI, Nigro MA, Wishnow R.

Arch Neurol. 1990 Nov;47(11):1208-9.

PMID:
2146943
11.

Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children.

Escolar DM, Henricson EK, Mayhew J, Florence J, Leshner R, Patel KM, Clemens PR.

Muscle Nerve. 2001 Jun;24(6):787-93.

PMID:
11360262
12.

Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation. FSH-DY Group.

Griggs RC, Tawil R, McDermott M, Forrester J, Figlewicz D, Weiffenbach B.

Muscle Nerve Suppl. 1995;2:S50-5.

PMID:
7739626
13.

Facioscapulohumeral muscular dystrophy.

Tawil R, Van Der Maarel SM.

Muscle Nerve. 2006 Jul;34(1):1-15. Review.

PMID:
16508966
14.

Facioscapulohumeral muscular dystrophy: a prospective study of weakness and functional impairment.

Stübgen JP, Stipp A.

J Neurol. 2010 Sep;257(9):1457-64. doi: 10.1007/s00415-010-5544-1. Epub 2010 Mar 30.

PMID:
20352247
15.

Facioscapulohumeral muscular dystrophy in early childhood.

Brouwer OF, Padberg GW, Wijmenga C, Frants RR.

Arch Neurol. 1994 Apr;51(4):387-94. Review.

PMID:
8155016
16.

Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD).

Gilbert JR, Stajich JM, Wall S, Carter SC, Qiu H, Vance JM, Stewart CS, Speer MC, Pufky J, Yamaoka LH, et al.

Am J Hum Genet. 1993 Aug;53(2):401-8.

17.

[Abnormal head drooping in facioscapulohumeral muscular dystrophy].

Ichikawa Y, Yamada H, Motoyoshi Y, Shimizu T, Kawai M.

Rinsho Shinkeigaku. 1996 Mar;36(3):503-6. Japanese.

PMID:
8741360
18.

Hearing loss in facioscapulohumeral muscular dystrophy.

Brouwer OF, Padberg GW, Ruys CJ, Brand R, de Laat JA, Grote JJ.

Neurology. 1991 Dec;41(12):1878-81.

PMID:
1745341
19.

Measurement of the functional status of patients with different types of muscular dystrophy.

Lue YJ, Lin RF, Chen SS, Lu YM.

Kaohsiung J Med Sci. 2009 Jun;25(6):325-33. doi: 10.1016/S1607-551X(09)70523-6.

20.

Molecular genetics of facioscapulohumeral muscular dystrophy (FSHD).

Fisher J, Upadhyaya M.

Neuromuscul Disord. 1997 Jan;7(1):55-62. Review.

PMID:
9132141

Supplemental Content

Support Center